HomeIFAN • OTCMKTS
add
Palantir Bioceuticals Inc
Previous close
$0.00020
Market cap
200.70K USD
Avg Volume
216.61K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2015info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.16M | 4,939.88% |
Net income | -2.38M | -5,584.81% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.13M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2015info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.85K | — |
Total assets | 5.02M | 1,685.83% |
Total liabilities | 1.45M | 365.72% |
Total equity | 3.57M | — |
Shares outstanding | 89.65M | — |
Price to book | 0.00 | — |
Return on assets | -50.85% | — |
Return on capital | -60.61% | — |
Cash Flow
Net change in cash
| (USD) | 2015info | Y/Y change |
|---|---|---|
Net income | -2.38M | -5,584.81% |
Cash from operations | -595.00K | -543.30% |
Cash from investing | -172.50K | -187.50% |
Cash from financing | 905.35K | 499.02% |
Net change in cash | 137.85K | 10,273.14% |
Free cash flow | 629.71K | 611,268.93% |
About
Founded
2010
Website
Employees
1
